Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's authority over supplement claims should be "strengthened" -- EPA advisory cmte..

This article was originally published in The Tan Sheet

Executive Summary

FDA's AUTHORITY OVER SUPPLEMENTS SHOULD BE "REAFFIRMED AND STRENGTHENED," according to a June 13 draft report for public review and comment issued by the Commission on Risk Assessment and Risk Management. A 10-member advisory committee to the U.S. Environmental Protection Agency with representation from government and academia, the commission is slated to hold a public hearing in Boston on July 23.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085480

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel